X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home News

Qatar approves emergency use of Modernas COVID-19 vaccine

Content Team by Content Team
14th February 2021
in News
Qatar approves emergency use of Modernas COVID-19 vaccine

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Qatari authorities have issued an emergency use authorisation for Moderna’s COVID-19 vaccine, the second coronavirus jab approved in the country after the one developed by Pfizer and BioNTech.

The Ministry of Public Health (MOPH) said the move on Wednesday came after an extensive review of the vaccine.

“The comprehensive clinical trial process on Moderna’s COVID-19 vaccine has showed it is safe and highly effective,” Dr Abdullatif Al Khal, chair of the National Health Strategic Group on COVID-19 and head of infectious diseases department at Hamad Medical Corporation, was cited by the QNA news agency as saying.

“The authorisation from MOPH means we can soon begin administering the Moderna vaccine along with the Pfizer and BioNTech vaccine as we expand our national vaccination programme in Qatar,” he added.

To date, Qatar has registered 155,453 coronavirus infections and 253 related deaths. Last week, authorities announced a 32-point plan to curb a surge in cases that has raised fears of a new wave of infections.

The small Gulf country in January recorded an 85 percent increase in the number of COVID-19 patients being admitted to hospital compared to the previous month.

Al Khal said that with high demand for COVID-19 vaccines around the world, Qatar will now benefit from the availability of two vaccines.

He added that both vaccines have shown similarly high levels of safety and efficacy in trials and that people should not be concerned about which vaccine they are offered.

Meanwhile, Dr Aisha Ibrahim Al Ansari, director of Pharmacy and Drug Control and the chair of the Vaccine Procurement Taskforce in Qatar, said: “Qatar’s proactive approach to securing vaccine agreements has proved highly effective.”

“We were clear from the outset that we only wanted to administer internationally-approved, safe and effective vaccines for the people of Qatar,” she said.

“We will soon receive the first delivery of Moderna vaccines and while this will be a limited quantity initially, this is an encouraging development and we can expect regular, larger deliveries of both Moderna and Pfizer and BioNTech vaccines to arrive in Qatar in the next days and weeks.”

Previous Post

Sepha launches small batch Contract Packaging Service

Next Post

Evonik strengthens strategic partnership with BioNTech on COVID-19 vaccine

Related Posts

idiopathic pulmonary fibrosis
Americas

US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

9th October 2025
Tissue Repair Drug
Clinical Trials

FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

7th October 2025
FastTrack Review
Americas

US FDA Launches Fast-Track Review Scheme for Generic Drugs

7th October 2025
AI Based Drug Discovery
Drug Development

Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

1st October 2025
API Manufacturing Facility
Americas

AbbVie Launches New API Manufacturing Facility in Illinois

1st October 2025
U.S. manufacturing
Americas

Amgen to Expand U.S. Manufacturing with $650M Investment

30th September 2025
Next Post
Johnson & Johnson Prepares to Resume Phase 3 ENSEMBLE Trial of its Janssen COVID-19 Vaccine Candidate in the U.S.

Evonik strengthens strategic partnership with BioNTech on COVID-19 vaccine

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In